Haider Salih Jaffat
Biographic Data
| ID | 8437606 |
|---|---|
| NAME | Haider Salih Jaffat |
| GIVEN NAMES | Haider Salih |
| FAMILY NAME | Jaffat |
| SIGNATURE | JAFFAT H S |
| AFFILIATIONS | University of Kufa |
| ORCID | 0000-0002-4023-6072 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Physiological study of NGAL and Cystatin C in chronic and acute kidney disease patients
Kidney disease is an important global health concern, affecting ~15% of the global population and typically associated with systemic disorders (e.g., diabetes). Increased incidence of kidney diseases and their progression to critical stages are facing many nations across the globe. The current study was performed with 65 male patients (20 with Acute kidney disease and 45 with chronic kidney disease, their mean age (44.38±14.59) years, who have vi…
NGAL as a biomarker in chronic kidney disease
The current study was performed with 65 patients with Chronic kidney disease, their mean age (44.38±14.59) years, who have visited the physician's consultancies and the kidney disease unit at Al-Sadder Teaching hospital in Al-Najaf, Iraq, and 25 persons as a healthy control group their mean age (48.68±16.37) years. The study was conducted from September 2021 to May 2022. In this study, serum NGAL levels were measured in patients and healthy group…
No prominent works on this page.
Physiological study of NGAL and Cystatin C in chronic and acute kidney disease patients
Kidney disease is an important global health concern, affecting ~15% of the global population and typically associated with systemic disorders (e.g., diabetes). Increased incidence of kidney diseases and their progression to critical stages are facing many nations across the globe. The current study was performed with 65 male patients (20 with Acute kidney disease and 45 with chronic kidney disease, their mean age (44.38±14.59) years, who have vi…
NGAL as a biomarker in chronic kidney disease
The current study was performed with 65 patients with Chronic kidney disease, their mean age (44.38±14.59) years, who have visited the physician's consultancies and the kidney disease unit at Al-Sadder Teaching hospital in Al-Najaf, Iraq, and 25 persons as a healthy control group their mean age (48.68±16.37) years. The study was conducted from September 2021 to May 2022. In this study, serum NGAL levels were measured in patients and healthy group…
Biology (2 works) · Biomarker (2 works) · Gastroenterology (2 works) · Internal Medicine (2 works) · Kidney (2 works) · Kidney disease (2 works) · Medicine (2 works) · Renal function (2 works) · Acute kidney injury (1 work) · Biomarkers in Disease Mechanisms (1 work)